Avantor EVP granted RSUs and 246K stock options
Avantor, Inc. executive Ludovic Brellier, EVP, Bioscience & Medtech, received new equity awards.
Rhea-AI Filing Summary
Avantor, Inc. executive Ludovic Brellier, EVP, Bioscience & Medtech, received new equity awards. He was granted 146,566 shares of common stock in the form of restricted stock units that vest in three equal annual installments beginning on May 1, 2027. Following this grant, he holds 146,566 common shares directly. He also received 246,002 stock options to buy common stock at an exercise price of $8.76 per share, which vest in three equal annual installments starting on May 1, 2027 and expire on May 1, 2036. These awards are part of his compensation, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 246,002 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 146,566 | $0.00 | $0.00 |
Footnotes (2)
- F1. Reflects a grant of restricted stock units that vest in three equal annual installments beginning on May 1, 2027.
- F2. Reflects a grant of stock options that vest in three equal annual installments beginning on May 1, 2027.
Key Figures
Key Terms
restricted stock units financial
stock options financial
exercise price financial
Form 4 regulatory
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Avantor (AVTR) executive Ludovic Brellier receive?
When do Ludovic Brellier’s Avantor (AVTR) restricted stock units vest?
What are the key terms of Ludovic Brellier’s Avantor (AVTR) stock options?
Are Ludovic Brellier’s Avantor (AVTR) equity awards open-market purchases or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.